跳到正文
原文
Medical Xpress·· 9 天前精选AI 评分75

研究发现长期有效的抗抑郁药

Study identifies antidepressants that get patients well and keep them well

AI 导读

一项国际研究比较了20种抗抑郁药的长期疗效,发现escitalopram、agomelatine和duloxetine在长期使用中表现更佳。研究结果有助于临床选择抗抑郁药,但强调个体差异需综合考虑药物的益处和副作用。

推荐理由

研究比较了多种抗抑郁药的长期有效性,为临床选择提供依据。

正文 · 原文
content person
Credit: Harun from Pexels

Worldwide, nearly 6% of people experience depression. Many of them continue taking antidepressants after achieving symptomatic improvement, among other reasons to prevent a relapse of depression. An international team of researchers investigated which antidepressants, if any, can not only get patients well but also keep them well (sustained response).

This is the first large-scale study to compare different antidepressants for both short- and long-term use. Results have been published in The Lancet Psychiatry.

Comparing long-term effectiveness

This study utilized evidence from 115 previously conducted randomized clinical trials, involving more than 30,000 participants in total. Researchers compared 20 antidepressants with one another and with the best-known antidepressant, fluoxetine. Results suggest that antidepressants can indeed keep people well during long-term use as well. Moreover, the study found evidence of differences between the various medications. These findings should inform the initial choice of antidepressants in view of their potential long-term use.

Three antidepressants were found to be more effective in the long term: escitalopram, agomelatine and duloxetine. These medications performed better than fluoxetine. "Escitalopram is already widely used," says first author Paul van Haaren. "Agomelatine works well, but one of its side effects is the risk of liver failure. Duloxetine is less well known and is prescribed less frequently as a first-line treatment."

Guidelines and individual treatment choices

Many international guidelines advise SSRIs as first-choice antidepressants. "Of these SSRIs, escitalopram now appears to be the most effective, also for long-term use. This study may have implications for future treatment guidelines," says Eric Ruhé, professor of difficult-to-treat depression at Radboud University Medical Center.

According to Ruhé, this does not mean that everyone with severe depression should now receive escitalopram. "As a prescriber, you consider the balance between a medication's benefits and side effects. That balance differs from person to person. Therefore, the choice of medication may vary for each individual patient. Nevertheless, our study can help inform the decisions that prescribers and patients make together: if you start an antidepressant, choose one that not only helps you to get well, but also keeps you well."

Publication details

Comparative efficacy and acceptability of antidepressants in the long-term treatment of major depressive disorder: a systematic review and network meta-analysis, The Lancet Psychiatry (2026). DOI: 10.1016/S2215-0366(26)00326-3

Journal information: The Lancet Psychiatry

Who's behind this story?

Sadie Harley

Sadie Harley

BSc Life Sciences & Ecology. Microbiology lab background with pharmaceutical news experience in oil, gas, and renewable industries. Full profile →

Andrew Zinin

Andrew Zinin

Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →

Citation: Study identifies antidepressants that get patients well and keep them well (2026, November 10) retrieved 10 November 2026 from https://medicalxpress.com/news/2026-11-antidepressants-patients.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

来源:Medical Xpress · medicalxpress.com